A detailed history of Wealth Alliance transactions in Glaukos Corp stock. As of the latest transaction made, Wealth Alliance holds 2,096 shares of GKOS stock, worth $310,962. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,096
Previous 2,081 0.72%
Holding current value
$310,962
Previous $246,000 10.98%
% of portfolio
0.03%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$113.62 - $135.39 $1,704 - $2,030
15 Added 0.72%
2,096 $273,000
Q2 2024

Aug 09, 2024

BUY
$89.48 - $118.35 $186,207 - $246,286
2,081 New
2,081 $246,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.06B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Wealth Alliance Portfolio

Follow Wealth Alliance and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Alliance, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Alliance with notifications on news.